Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026)

Penumbra's (PEN) quarterly Change in Acquisitions & Divestments came in at $125.1 million in Q1 2026, up 862.61% year-on-year from $13.0 million in Q1 2025, and up 862.61% on a QoQ basis from $13.0 million in Q1 2025.

Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026) Analysis & Trends

Penumbra (PEN) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $125.1 million in Q1 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments rose 862.61% year-over-year to $125.1 million in Q1 2026; TTM through Mar 2026 was $125.1 million, a 24.84% increase from a year earlier, with the FY2025 full-year figure at $13.0 million, down 90.05% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $125.1 million, up from $13.0 million in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for PEN reached as high as $125.1 million in Q1 2026 and fell as low as -$59.5 million in Q4 2022.
  • Historically, Change in Acquisitions & Divestments has averaged $25.2 million across 5 years, with a median of $19.4 million in 2022.
  • Across the five-year window, Change in Acquisitions & Divestments slumped 149.73% in 2022 and surged 862.61% in 2026, its largest moves.
  • Year by year, Change in Acquisitions & Divestments stood at -$59.5 million in 2022, then jumped by 161.3% to $36.5 million in 2023, then slumped by 86.85% to $4.8 million in 2024, then soared by 170.83% to $13.0 million in 2025, then jumped by 862.61% to $125.1 million in 2026.
  • Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $125.1 million in Q1 2026, $13.0 million in Q1 2025, and $4.8 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Penumbra 12.55 Bn 11.94 Bn 253.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 125.14 Mn
Mar 31, 2026 125.14 Mn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 4.80 Mn
Dec 31, 2024 4.80 Mn
Sep 30, 2024 42.89 Mn
Sep 30, 2024 42.89 Mn
Jun 30, 2024 39.55 Mn
Jun 30, 2024 39.55 Mn
Mar 31, 2024 43.38 Mn
Mar 31, 2024 43.38 Mn
Dec 31, 2023 36.50 Mn
Dec 31, 2023 36.50 Mn
Sep 30, 2023 18.10 Mn
Sep 30, 2023 18.10 Mn
Jun 30, 2023 13.37 Mn
Jun 30, 2023 13.37 Mn
Mar 31, 2023 14.61 Mn
Mar 31, 2023 14.61 Mn